Pluri Inc.
General ticker "PLUR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $142.9M (TTM average)
Pluri Inc. does not follow the US Stock Market performance with the rate: -16.7%.
Estimated limits based on current volatility of 1.6%: low 3.47$, high 3.59$
Factors to consider:
- Total employees count: 118 (-11.9%) as of 2024
- Top business risk factors: Operational and conduct risks, Need for additional capital, IP disputes, Regulatory and compliance, IP protection
- Price in estimated range
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-06-30 to 2027-06-30
- 2025-06-30 to 2026-06-30 estimated range: [2.64$, 7.10$]
- 2026-06-30 to 2027-06-30 estimated range: [2.33$, 6.37$]
Financial Metrics affecting the PLUR estimates:
- Positive: with PPE of -0.9 at the end of fiscal year the price was neutral
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -62.46 <= 0.01
- Negative: Shareholder equity ratio, % of -17.69 <= 19.40
- Positive: Interest expense per share per price, % of 2.99 <= 3.28
- Positive: Return on assets ratio (scaled to [-100,100]) of 37.54 > 6.11
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: Investing cash flow per share per price, % of 27.53 > -0.63
Short-term PLUR quotes
Long-term PLUR plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating Revenue | $0.29MM | $0.33MM | $1.34MM |
| Operating Expenses | $27.53MM | $22.48MM | $23.51MM |
| Operating Income | $-27.25MM | $-22.16MM | $-22.18MM |
| Non-Operating Income | $-1.64MM | $0.81MM | $-1.08MM |
| Interest Expense | $0.84MM | $0.87MM | $0.87MM |
| R&D Expense | $15.74MM | $12.45MM | $12.85MM |
| Income(Loss) | $-28.89MM | $-21.34MM | $-23.25MM |
| Taxes | $0.00MM | $0.00MM | $0.01MM |
| Profit(Loss)* | $-28.32MM | $-20.89MM | $-22.58MM |
| Stockholders Equity | $13.36MM | $0.10MM | $-6.84MM |
| Assets | $50.80MM | $39.53MM | $38.68MM |
| Operating Cash Flow | $-22.86MM | $-18.02MM | $-18.21MM |
| Capital expenditure | $0.26MM | $0.32MM | $1.62MM |
| Investing Cash Flow | $9.70MM | $10.58MM | $8.03MM |
| Financing Cash Flow | $8.02MM | $8.84MM | $9.53MM |
| Earnings Per Share** | $-6.18 | $-3.99 | $-3.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.